Mario Gabelli Boston Scientific Corp Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Boston Scientific Corp stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 120,290 shares of BSX stock, worth $11 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

120,290

Previous 103,324 16.42%

Holding current value

$11 Million

Previous $7.96 Million 26.7%

% of portfolio

0.11%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $1.24 Million - $1.43 Million	16,966 Added 16.42%	120,290 $10.1 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $3.96 Million - $4.57 Million	58,861 Added 132.38%	103,324 $7.96 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $475,200 - $566,115	-8,250 Reduced 15.65%	44,463 $3.05 Million
Q3 2023 Nov 08, 2023	SELL	$50.19 - $54.68 $334,265 - $364,168	-6,660 Reduced 11.22%	52,713 $2.78 Million
Q2 2023 Aug 10, 2023	SELL	$49.72 - $54.64 $223,740 - $245,880	-4,500 Reduced 7.05%	59,373 $3.21 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $121,743 - $135,081	-2,700 Reduced 4.06%	63,873 $3.2 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $122,636 - $146,382	-3,100 Reduced 4.45%	66,573 $3.08 Million
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $66,078 - $197,388	-1,800 Reduced 2.52%	69,673 $2.7 Million
Q2 2022 Aug 12, 2022	BUY	$35.24 - $47.1 $14,096 - $18,840	400 Added 0.56%	71,473 $2.66 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $397,139 - $437,921	-9,710 Reduced 12.02%	71,073 $3.15 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $95,175 - $112,175	2,500 Added 3.19%	80,783 $3.43 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $419,102 - $466,370	10,165 Added 14.92%	78,283 $3.4 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $10,802 - $12,387	-280 Reduced 0.41%	68,118 $2.91 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $114,627 - $128,927	-3,250 Reduced 4.54%	68,398 $2.64 Million
Q4 2020 Feb 05, 2021	SELL	$33.15 - $41.97 $235,365 - $297,987	-7,100 Reduced 9.02%	71,648 $2.58 Million
Q3 2020 Nov 06, 2020	SELL	$34.44 - $42.23 $195,722 - $239,993	-5,683 Reduced 6.73%	78,748 $3.01 Million
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $570,591 - $739,179	-18,900 Reduced 18.29%	84,431 $2.96 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $450,733 - $797,639	-17,450 Reduced 14.45%	103,331 $3.37 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $1.53 Million - $1.83 Million	-40,333 Reduced 25.03%	120,781 $5.46 Million
Q3 2019 Nov 01, 2019	SELL	$40.31 - $43.45 $632,867 - $682,165	-15,700 Reduced 8.88%	161,114 $6.56 Million
Q2 2019 Aug 02, 2019	SELL	$34.91 - $42.98 $1.17 Million - $1.44 Million	-33,500 Reduced 15.93%	176,814 $7.6 Million
Q1 2019 May 02, 2019	SELL	$32.91 - $40.75 $556,179 - $688,675	-16,900 Reduced 7.44%	210,314 $8.07 Million
Q4 2018 Jan 30, 2019	SELL	$31.73 - $39.04 $334,751 - $411,872	-10,550 Reduced 4.44%	227,214 $8.03 Million
Q3 2018 Nov 02, 2018	SELL	$32.83 - $38.63 $2.44 Million - $2.87 Million	-74,300 Reduced 23.81%	237,764 $9.15 Million
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $519,219 - $663,920	-19,345 Reduced 5.84%	312,064 $10.2 Million
Q1 2018 May 09, 2018	SELL	$25.2 - $28.54 $3.06 Million - $3.47 Million	-121,500 Reduced 26.83%	331,409 $9.05 Million
Q4 2017 Feb 02, 2018	SELL	$24.79 - $29.8 $1.86 Million - $2.23 Million	-74,950 Reduced 14.2%	452,909 $11.2 Million
Q3 2017 Nov 01, 2017	BUY	$26.26 - $29.17 $13.9 Million - $15.4 Million	527,859	527,859 $15.4 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account